These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34699874)

  • 1. An update on factor XII-driven vascular inflammation.
    Mailer RK; Rangaswamy C; Konrath S; Emsley J; Renné T
    Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119166. PubMed ID: 34699874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
    Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
    Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XII in coagulation, inflammation and beyond.
    Didiasova M; Wujak L; Schaefer L; Wygrecka M
    Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
    Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
    Schousboe I
    Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XII truncation accelerates activation in solution.
    de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
    J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo roles of factor XII.
    Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
    Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces.
    Konrath S; Mailer RK; Renné T
    Hamostaseologie; 2021 Dec; 41(6):489-501. PubMed ID: 34592776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.
    Worm M; Köhler EC; Panda R; Long A; Butler LM; Stavrou EX; Nickel KF; Fuchs TA; Renné T
    Ann Transl Med; 2015 Oct; 3(17):247. PubMed ID: 26605293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact system revisited: an interface between inflammation, coagulation, and innate immunity.
    Long AT; Kenne E; Jung R; Fuchs TA; Renné T
    J Thromb Haemost; 2016 Mar; 14(3):427-37. PubMed ID: 26707513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of Factor XII in Innate Immunity.
    Renné T; Stavrou EX
    Front Immunol; 2019; 10():2011. PubMed ID: 31507606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in factor XII structure and function.
    Shamanaev A; Litvak M; Gailani D
    Curr Opin Hematol; 2022 Sep; 29(5):233-243. PubMed ID: 35916558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XII: a novel target for safe prevention of thrombosis and inflammation.
    Kenne E; Nickel KF; Long AT; Fuchs TA; Stavrou EX; Stahl FR; Renné T
    J Intern Med; 2015 Dec; 278(6):571-85. PubMed ID: 26373901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation.
    Clermont AC; Murugesan N; Edwards HJ; Lee DK; Bayliss NP; Duckworth EJ; Pethen SJ; Hampton SL; Gailani D; Feener EP
    Front Pharmacol; 2023; 14():1287487. PubMed ID: 38178859
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid and cooperative binding of factor XII to human umbilical vein endothelial cells.
    Schousboe I
    Eur J Biochem; 2001 Jul; 268(14):3958-63. PubMed ID: 11453989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
    Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
    J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function.
    Liu J; Cooley BC; Akinc A; Butler J; Borodovsky A
    Thromb Res; 2020 Dec; 196():200-205. PubMed ID: 32896690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XII Contact Activation.
    Naudin C; Burillo E; Blankenberg S; Butler L; Renné T
    Semin Thromb Hemost; 2017 Nov; 43(8):814-826. PubMed ID: 28346966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary study on the effects of coagulation factor XII on fibrinolysis].
    Hu Y; Wang H; Jiao J; Wang Y; Yu W; Ling X
    Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):466-8. PubMed ID: 11877020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.